Schroll Medical
Mariolla Dolleris Schroll is a seasoned professional in the medical cannabis industry and business development, currently serving as the Chairman of the MCI board since 2023, following roles as Vice Chairman and board member from 2019 to 2022. As the Public Relations Officer at Schroll Medical ApS since 2018, Mariolla has advocated for the regulatory interests of the medical cannabis sector in Denmark, focusing on enhancing the legislative framework for the production of high-quality EU GMP products. Additionally, as a professional in business development at Schroll-flowers since 2013, notable work includes trademark applications and achieving several US plant patents. Previous experience includes roles as Senior Project Business Analyst and Business Consultant at ALOC A/S, and Business Analyst and System Developer at Aloc Bonnier A/S, with a solid educational background in Mathematics-Economics and Banking and Financial Support Services from the University of Southern Denmark.
This person is not in any teams
This person is not in any offices
Schroll Medical
Schroll Medical is a EU-GMP certified breeder, cultivator and manufacturer of medicinal cannabis flower and full spectrum extract based in Odense, Denmark. We use our extensive knowledge and experience in breeding and growing standardized plants at scale to make medicinal cannabis available and affordable to patients all across Europe. We call that vision SCALING PLANT-BASED CANNABINOIDS, to improve quality of life for patients in Europe. Since the inception i 2018, Schroll Medical has grown to 40 employees across Denmark and Portugal and have launched their products in 5 countries with more to come. Cannabis is bred in greenhouses near Odense in Denmark and produced at scale in both Denmark and Portugal.